New Scientific Research Provides Link Between Globo-series Glycosphingolipid (GSL) Antigens and Tumor Survival in Breast Cancer

Thursday, February 14, 2019 Research News
Email Print This Page Comment bookmark
Font : A-A+

Study supports the anti-Globo series cancer pipeline under development by OBI Pharma Inc.

[1]

"Signaling pathway of globo-series glycosphingolipids and ?1,3-galactosyltransferase V (?3GalT5) in breast cancer." Proceedings of the National Academy of Sciences (PNAS), Published ahead of printáFebruary 11, 2019. https://doi.org/10.1073/pnas.1816946116á



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store